Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Spruce Biosciences (SPRB) Assets Average (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Assets Average for 4 consecutive years, with $34.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Assets Average fell 38.05% to $34.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $34.2 million, a 38.05% decrease, with the full-year FY2025 number at $49.1 million, down 34.14% from a year prior.
  • Assets Average was $34.2 million for Q4 2025 at Spruce Biosciences, up from $18.6 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $132.5 million in Q2 2023 to a low of $18.6 million in Q3 2025.
  • A 4-year average of $79.6 million and a median of $90.5 million in 2022 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: increased 20.76% in 2023, then crashed 73.59% in 2025.
  • Spruce Biosciences' Assets Average stood at $90.5 million in 2022, then rose by 19.89% to $108.5 million in 2023, then tumbled by 49.15% to $55.2 million in 2024, then plummeted by 38.05% to $34.2 million in 2025.
  • Per Business Quant, the three most recent readings for SPRB's Assets Average are $34.2 million (Q4 2025), $18.6 million (Q3 2025), and $26.7 million (Q2 2025).